Please enter your credentials to continue.
Asia
Africa
Australia
China
Europe
Canada
Middle East
United Kingdom
United States
>>
Merck‘s antibody-drug conjugate (ADC) licensed from China succeeded in a Phase 3 trial for non-small cell lung cancer. The Silicon Review report...
Ten midsize biotech companies launched the Midsized Biotech Alliance of America to combat the Trump administration's Most Favored Nation drug pricing ...
The FDA reversed course and accepted Moderna's revised mRNA flu vaccine application just eight days after a refusal, with an August 2026 decision dead...
The FDA issued a rare refusal-to-file letter for Moderna’s mRNA-1010 flu shot over comparator concerns. Moderna calls the move “inconsiste...
Eikon Therapeutics raises $381M in a major biotech IPO, marking 2026's third successful public offering for the sector amid renewed investor optimism....